Related Experiment Video
Updated: Jul 20, 2026

Determination of Tolerable Fatty Acids and Cholera Toxin Concentrations Using Human Intestinal Epithelial Cells and BALB/c Mouse Macrophages
Published on: May 30, 2013
Summary of the thirty-first United States-Japan Joint Conference on Cholera and Related Diarrheal Diseases
1Enteric Diseases Branch, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20895-2520, USA.
Abstract:
The 31st United States-Japan Cholera and Related Diarrheal Diseases Conference was held in conjunction with the United States-Japan Malnutrition Conference at Kiawah Island, South Carolina, 30 November to 3 December 1995. In addition to the overall conference theme of the role of cytokines in the pathogenesis of enteric infections and malnutrition, researchers described substantial advances in cholera epidemiology, detection, molecular mechanisms, and pathophysiology plus new mechanisms for enterotoxigenic, enteroadherent, enterohemorrhagic, and enteroinvasive Escherichia coli. There was also emphasis on new work with and vaccine development with Bacteroides fragilis and Yersinia, Shigella, and Salmonella species.
Related Concept Videos
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Methods Of Healthcare Delivery System
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Cholera

